Endpoints News

Sanofi extends $180M to California T cell engager startup Kali

Published

on

Sanofi is back in the T cell engager business after a couple years of fluctuating interest, extending its support to a relatively unknown California startup in a large upfront deal that …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version